Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.55 |
| ▸ | NAAA | Q02083 | 1/20 | 0.53 |
| ▸ | FAAH | O00519 | 1/20 | 0.49 |
| ▸ | ACHE | P22303 | 6/20 | 0.48 |
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.47 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.46 |
| ▸ | RAD52 | P43351 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL116383 | 1.00 | EPHX1 (0.55) | EPHX1NAAAFAAHACHETSHR | |
| SCHEMBL15796303 | 0.92 | EPHX1 (0.52) | EPHX1NAAAFAAHACHETSHR | |
| SCHEMBL18510017 | 0.92 | ALDH1A1 (0.52) | EPHX1NAAAACHETSHRZDHHC7 | |
| SCHEMBL18510055 | 0.92 | ALDH1A1 (0.52) | EPHX1NAAAACHETSHRZDHHC7 | |
| SCHEMBL851835 | 0.91 | EPHX1 (0.47) | EPHX1NAAAFAAHACHETSHR | |
| SCHEMBL851488 | 0.91 | EPHX1 (0.47) | EPHX1NAAAFAAHACHETSHR | |
| Hydrochloric Acid SCHEMBL15569070 | 0.91 | EPHX1 (0.50) | EPHX1NAAAFAAHACHETSHR | |
| SCHEMBL593216 | 0.90 | EPHX1 (0.46) | EPHX1NAAAFAAHACHETSHR | |
| SCHEMBL16929671 | 0.87 | EPHX1 (0.46) | EPHX1NAAAFAAHACHETSHR | |
| SCHEMBL15796558 | 0.86 | EPHX1 (0.58) | EPHX1NAAAFAAHACHETSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12473379-B2 | Method for obtaining purified bacterial polysaccharides | SERUM INSTITUTE OF INDIA PRIVATE LIMITED (IN) | 2025-11-18 | — | — | US | claimed |
| CN-113101300-A | Medical device for preventing and/or treating infection of skin injury | 法斯特麦德意大利有限公司 | 2021-07-13 | — | — | CN | claimed |
| US-20210070890-A1 | METHOD FOR OBTAINING PURIFIED BACTERIAL POLYSACCHARIDES | SERUM INSTITUTE OF INDIA PRIVATE LIMITED (IN) | 2021-03-11 | — | — | US | claimed |
| EP-3789494-A1 | METHOD FOR OBTAINING PURIFIED BACTERIAL POLYSACCHARIDES | Serum Institute of India Private Limited (IN) | 2021-03-10 | — | — | EP | claimed |
| EP-2436700-B1 | SHORTENED PURIFICATION PROCESS FOR THE PRODUCTION OF CAPSULAR STREPTOCOCCUS PNEUMONIAE POLYSACCHARIDES | WYETH LLC (US) | 2018-06-20 | — | — | EP | claimed |
| CN-106398306-A | Pigment preparing product used for acrylon stock solution dying, and preparation method thereof | 苏州世名科技股份有限公司 | 2017-02-15 | — | — | CN | claimed |
| EP-2129693-B1 | SHORTENED PURIFICATION PROCESS FOR THE PRODUCTION OF CAPSULAR STREPTOCOCCUS PNEUMONIAE POLYSACCHARIDES | WYETH LLC (US) | 2016-12-07 | — | — | EP | claimed |
| CN-104994864-A | Stable aqueous composition comprising human insulin or an analogue or derivative thereof | WOCKHARDT LTD | 2015-10-21 | — | — | CN | claimed |
| US-8999697-B2 | Shortened purification process for the production of capsular Streptococcus pneumoniae polysaccharides | WYETH LLC (US) | 2015-04-07 | — | — | US | claimed |
| US-20140363463-A1 | SHORTENED PURIFICATION PROCESS FOR THE PRODUCTION OF CAPSULAR STREPTOCOCCUS PNEUMONIAE POLYSACCHARIDES | WYETH LLC (US) | 2014-12-11 | — | — | US | claimed |
| EP-2129693-A2 | SHORTENED PURIFICATION PROCESS FOR THE PRODUCTION OF CAPSULARSTREPTOCOCCUS PNEUMONIAE POLYSACCHARIDES | Wyeth (US) | 2009-12-09 | — | — | EP | claimed |
| US-20080286838-A1 | SHORTENED PURIFICATION PROCESS FOR THE PRODUCTION OF CAPSULAR STREPTOCOCCUS PNEUMONIAE POLYSACCHARIDES | WYETH (US) | 2008-11-20 | — | — | US | claimed |
| WO-2008118752-A2 | SHORTENED PURIFICATION PROCESS FOR THE PRODUCTION OF CAPSULAR STREPTOCOCCUS PNEUMONIAE POLYSACCHARIDES | WYETH (US) | 2008-10-02 | — | — | WO | claimed |
| US-12473379-B2 | Method for obtaining purified bacterial polysaccharides | SERUM INSTITUTE OF INDIA PRIVATE LIMITED (IN) | 2025-11-18 | — | — | US | disclosed |
| US-12343389-B2 | Streptococcus pneumoniae capsular polysaccharides and conjugates thereof | PFIZER INC. (US) | 2025-07-01 | — | — | US | disclosed |
| US-20250163484-A1 | Methods for Incorporating Azido Groups in Bacterial Capsular Polysaccharides | PFIZER (US) | 2025-05-22 | — | — | US | disclosed |
| WO-2000044864-A1 | BAR COMPOSITIONS CONTAINING SOLID AMPHOTERIC SURFACTANTS | UNILEVER PLC (GB) | 2000-08-03 | — | — | WO | disclosed |
| US-5786319-A | LIQUID DETERGENT COMPRISING GLYCOL ETHER SOLVENT SYSTEM, NONIONIC SURFACTANT, HYDROTROPE STABLY DISPERSED IN WATER | DIVERSEY LEVER, INC. (US) | 1998-07-28 | — | — | US | disclosed |
| EP-0840778-A1 | CONCENTRATED AQUEOUS DEGREASING CLEANSER | UNILEVER N.V. (NL) | 1998-05-13 | — | — | EP | disclosed |
| WO-1997004069-A1 | CONCENTRATED AQUEOUS DEGREASING CLEANSER | UNILEVER N.V. (NL) | 1997-02-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12343389-B2 | Streptococcus pneumoniae capsular polysaccharides and conjugates thereof | STT3B, VGF, STT3A | EPHX1 4613/4885NAAA 2379/4885FAAH 4861/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.